Edgewise Therapeutics
IPOA Movement in Muscle
Public · Boulder, United States · Founded 2017 · $585.0M raised
- Headquarters
- Boulder, Colorado
- Employees
- 51–200
- Founded
- 2017
- Business Model
- B2B
- Website
- edgewisetx.com
- Total Funding
- $585.0M
- Last Round
- $200.0M Growth EquityApr 2025
- Rounds
- 4
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel oral small-molecule therapies for serious skeletal and cardiac muscle diseases including Duchenne muscular dystrophy, Becker muscular dystrophy, and hypertrophic cardiomyopathy. Founded in 2017 and headquartered in Boulder, Colorado, the company uses its proprietary muscle biology platform to identify and advance muscle-selective drug candidates with the goal of improving function and quality of life for patients with rare muscle disorders.
Summary
Edgewise Therapeutics is a Biotech company based in Boulder, United States, founded in 2017. It has raised $585.0M in total across 4 rounds, most recently a $200.0M Growth Equity round in Apr 2025. Investors include Viking Global, USVP and OrbiMed.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Apr 2025
Sign up to see all 5 events
Funding: Series B through Growth Equity. Amounts, valuations, and investors where available.
Investors
Viking Global
1 round
USVP
1 round
OrbiMed
2 rounds
US Venture Partners
2 rounds
Braidwell LP
1 round
Cormorant Asset Management
1 round
Driehaus Capital Management
1 round
Invus
1 round
Janus Henderson Investors
1 round
Deerfield Management
1 round
New Leaf Ventures
1 round
CureDuchenne Ventures
1 round
Novo Holdings A/S
1 round
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/edgewise-therapeutics"><img src="https://indexed.vc/api/badge/company/edgewise-therapeutics" alt="Edgewise Therapeutics on Indexed.vc" width="260" height="76" /></a>